Bioneercorporation바이오니아
064550 · KOSDAQ · ₩064550 · 바이오니아
- Market cap
- ₩180B
- Enterprise value
- ₩140B
- P/E
- —
- P/B
- 0.9×
- Dividend yield
- 0.0%
- ROE
- −3.3%
- Net margin
- −1.9%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−55.4% from the high
₩5,470Today: ₩6,870 – ₩7,130₩15,640
Returns
- 1W−6.6%
- 1M−17.0%
- 3M+20.6%
- 6M−33.8%
- YTD−45.3%
- 1Y−51.9%
- Volume today
- 147,879
- 0.9× the 20-day average
- Traded today
- ₩1B
- Listed shares
- 25,810,291
- EPS (12 months)
- −₩259
- Earnings yield −3.7%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 40 of 100 (50 is a normal day for this stock).
- MomentumWeak-20% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
Bioneercorporation stock overview
Bioneercorporation (바이오니아, KRX: 064550) is listed on KOSDAQ, in the Biotech & Pharma sector. Bioneer is a Korean biohealthcare company developing gene-based solutions for diagnosis, treatment, and prevention of disease. Its shares closed at ₩6,980 on Oct 29, 2026, down 1.27% on the day, giving it a market value of ₩180B.
Key facts
- Market cap
- ₩180B
- Sector
- Biotech & Pharma
- Latest price change
- −1.27%
- As of
- Oct 29, 2026
- Main business
- Bioneer is a Korean biohealthcare company developing gene-based solutions for diagnosis, treatment, and prevention of disease.
Quick answers about Bioneercorporation
- What does Bioneercorporation do?
- Bioneer is a Korean biohealthcare company developing gene-based solutions for diagnosis, treatment, and prevention of disease. Its businesses include life science research products such as PCR and protein synthesis instruments, reagents and sequencing-related services, molecular diagnostics platforms and kits, probiotic functional foods through its subsidiary Ace Biome, and RNA interference drug development through its subsidiary Suna Genetherapeutics using its SAMiRNA siRNA platform. The company supplies research institutes, universities, companies, and public agencies in Korea and exports to about 50 countries.
- What is the market cap of Bioneercorporation?
- The market capitalisation of Bioneercorporation was ₩180B at the close on Oct 29, 2026.
- Who are the largest shareholders of Bioneercorporation?
- According to the latest official filings, the largest reported holders are Park Han-o (17.52%, as of Feb 4, 2026); VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND (1.17%, as of Jul 31, 2026); VANGUARD DEVELOPED MARKETS INDEX FUND (0.78%, as of Jun 30, 2026).
- When is the next earnings report from Bioneercorporation?
- Korean companies rarely announce results dates in advance. Based on when Bioneercorporation filed the same report in past years, its next 3q results is expected between Nov 13, 2026 and Nov 14, 2026.
- Does the National Pension Service own Bioneercorporation?
- Yes. The National Pension Service held 0.10% of Bioneercorporation shares as of Dec 31, 2025.
Company profile
Bioneer is a Korean biohealthcare company developing gene-based solutions for diagnosis, treatment, and prevention of disease. Its businesses include life science research products such as PCR and protein synthesis instruments, reagents and sequencing-related services, molecular diagnostics platforms and kits, probiotic functional foods through its subsidiary Ace Biome, and RNA interference drug development through its subsidiary Suna Genetherapeutics using its SAMiRNA siRNA platform. The company supplies research institutes, universities, companies, and public agencies in Korea and exports to about 50 countries.
Written by AI from the company's latest annual report.
- Korean name
- 바이오니아
- Sector
- Biotech & Pharma
- Themes
- Biotech (new drugs)
- CEO
- 박한오
- Founded
- Aug 1992
- Listed
- Dec 2005
- Listed shares
- 25,810,291
- Fiscal year ends
- Month 12
- Website
- www.bioneer.co.kr
Similar companies
- Samsung Biologics207940 · ₩63T₩1,366,000−0.44%
- Celltrion068270 · ₩44T₩189,300−0.26%
- Alteogen196170 · ₩15T₩220,000−1.35%
- SK biopharmaceuticals326030 · ₩6.1T₩77,800+3.46%
- Yuhan000100 · ₩5.5T₩74,700−3.36%
- HLB028300 · ₩5.3T₩39,700−2.34%
- Hanmi Pharm128940 · ₩5T₩388,500+5.14%
- SAM Chun Dang Pharm000250 · ₩4.4T₩188,600−0.74%
Recent filings
See all- Insider shareholding reportOct 12, 2026
- Insider shareholding reportOct 12, 2026
- Half-year report (Jun 2026)Aug 14, 2026
- Quarterly report (Mar 2026)May 15, 2026
- Change of Department AffiliationApr 30, 2026
Titles in Korean until English translations are added.
Also known as: Bioneercorporation / 바이오니아 / 064550 / KRX:064550
Source: KRX statistical information